Today on theDESK, the FDA is on the verge of approving a drug for women that acts much like Viagra, but there are serious side effects and questions about Flibanserin effectiveness.. Video published on 5 Jun 2015 by UPROXX.
More information
- Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee, FDA Briefing Document, June 4, 2015.
- Will the “female Viagra” really help women? #flibanserin and the #FDA approval or not
- A sexually satisfying event for women, or just a new identity for an old antidepressant?, theconversation, June 6, 2015.
- ‘Viagra for Women’ Is Backed by an F.D.A. Panel, nytimes, JUNE 4, 2015.
- ‘Female viagra’: FDA panel backs Flibanserin with safety restriction, theguardian, JUNE 4, 2015.
- FDA Advisory Committee Recommends Approval for Sprout Pharmaceuticals’ ADDYI™ (flibanserin) to Treat Hypoactive Sexual Desire Disorder in Premenopausal Women, Sprout Pharmaceuticals, Jun 5, 2015.
OK, great news I think!
the drug is full of side effects… and it’s not a one-off (as for men) ; you need to take it for a while to get potential results if any…
so, no, it’s no great news at all…